Filing Flows › GE HealthCare Technologies (GEHC) › Product revenue
GE HealthCare Technologies (GEHC) Product revenue by quarter
GE HealthCare Technologies' Product revenue was $3.6B in Q3 2026 (third quarter 2026), +5% from Q2 2026. Over the last 7 quarters it ranged from $3.1B (Q1 2025) to $3.9B (Q4 2025).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.6B | +5% | +7% |
| Q2 2026 | $3.4B | +2% | +5% |
| Q1 2026 | $3.3B | -14% | +7% |
| Q4 2025 | $3.9B | +16% | — |
| Q3 2025 | $3.4B | +3% | — |
| Q2 2025 | $3.3B | +5% | — |
| Q1 2025 | $3.1B | — | — |
Q3 2026 at a glance
GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%, net earnings $615M, operating cash flow $907M. The chart follows the revenue to costs, profit and cash.
Questions
What is GE HealthCare Technologies' Product revenue?
GE HealthCare Technologies' Product revenue was $3.6B in Q3 2026 (third quarter 2026), +5% from Q2 2026.
How has GE HealthCare Technologies' Product revenue changed?
Over the last 7 quarters it ranged from $3.1B (Q1 2025) to $3.9B (Q4 2025).
Q3 2026 results → · How GE HealthCare Technologies makes money →